Category survey

MOLECULAR ORCHESTRATION OF MITOCHONDRIAL FITNESS VIA REPLACEMENT OR REPAIR Investments < €500k United States of America 2016    

Linking Olfactory deficits to Neurodegenerative Disorders Investments < €500k United States of America 2016    

Investigating mechanisms of UBQLN2-mediated neurodegenerative disease Investments < €500k United States of America 2016    

A novel dual hit model of environmental risk factors for Parkinsons Disease Investments < €500k United States of America 2016    

Mechanisms Mediating NMJ Dennervation Investments < €500k United States of America 2016    

Alpha-synuclein is crucial for neuronal function and survival-Characterization of a novel conditional alpha-synuclein knockout mouse model Investments < €500k United States of America 2016    

Post-PT Extension of In-Home Dynamic Standing Table Use in Parkinson Disease Investments < €500k United States of America 2016    

Statistical Methods for Causal Inference in Observational Studies Investments < €500k United States of America 2016    

Mechanisms of C9orf72-associated dipeptide toxicity Investments < €500k United States of America 2016    

Modeling Synaptic Vulnerability of a Brainstem Sensorimotor Circuit in a Mouse Model for Amyotrophic Lateral Sclerosis Investments < €500k United States of America 2016    

Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons Investments < €500k United States of America 2016    

Indices of Motor Synergies as Early Biomarkers of Parkinsons Disease Investments < €500k United States of America 2016    

Molecular neuropathology of TDP-43 proteinopathies Investments < €500k United States of America 2016    

Characterizing Intrinsic Functional Cortical Networks in Parkinson Disease Dementia Investments < €500k United States of America 2016    

EPIGENETIC AND MRNA PROFILING OF STRIATOPALLIDAL NEURONS IN HUNTINGTONS DISEASE Investments < €500k United States of America 2016    

Development of DNAzyme Gene Therapy for Huntingtons Disease Investments < €500k United States of America 2016    

Exercise Intervention for Slowing HD Progression Investments < €500k United States of America 2016    

Lysosomal stress triggers exosome release and transfer of proteins Investments < €500k United States of America 2016    

Characterization of the Fidelity to PD of a Unique Rat Model Investments < €500k United States of America 2016    

The role of G3BP1 in mutant SOD1-mediated familial ALS Investments < €500k United States of America 2016    

Seeded transmission of SOD1 misfolding Investments < €500k United States of America 2016    

Cellular mechanisms underlying detoxification of mutant Huntingtin Investments < €500k United States of America 2016    

Investigating the contributions of astrocyte gap junctions to ALS disease progression Investments < €500k United States of America 2016    

NG2 cells in Huntingtons disease Investments < €500k United States of America 2016    

Understanding PDI-related neurotoxicity and advancing preventative approaches Investments < €500k United States of America 2016    

Striatal Nurr1 activity facilitates the dyskinetic state: A novel therapeutic target Investments < €500k United States of America 2016    

SMN dysfunction in FUS-dependent ALS Investments < €500k United States of America 2016    

Gene Therapy Targeting Striatal cGMP signaling in experimental parkinsonism Investments < €500k United States of America 2016    

Endogenous petides as markers of abnormal SOD-1 protein in familial and sporadic ALS Investments < €500k United States of America 2016    

Global RNA Interference Therapy for Huntingtons Disease Investments < €500k United States of America 2016    

Novel 3D brain tissue-based screening assay for targeting microglia in CNS neurodegeneration Investments < €500k United States of America 2016    

Translational regulation by DJ-1 Investments < €500k United States of America 2016    

PINK1 regulation of neuronal and mitochondrial homeostasis Investments < €500k United States of America 2016    

Optimization of Compounds that Stabilize the SMN Protein for Treatment of SMA Investments < €500k United States of America 2016    

Activation of the GPCR Smoothened as a treatment of L-Dopa Induced dyskinesia Investments < €500k United States of America 2016    

Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation Investments < €500k United States of America 2016    

Apoptotic neuronal cells serve as sources for spreading of human a-synuclein pathology in the brain Investments < €500k United States of America 2016    

Addressing the contribution of JNK3 to axonal pathology in Huntingtons disease Investments < €500k United States of America 2016    

Mechanisms of LRRK2 Mediated Dopaminergic Axonal Degeneration and Synaptic Transmission Deficits Investments < €500k United States of America 2016    

TTR and C9ORF72 in ALS and related disorders Investments < €500k United States of America 2016    

Elucidating the mechanism of mitochondrial quality control in Drosophila Investments < €500k United States of America 2016    

Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology Investments < €500k United States of America 2016    

The role of striatal cholinergic interneurons in Parkinson’s disease Investments < €500k United States of America 2016    

G-quadruplex Structures as Targets and Tools in ALS Investments < €500k United States of America 2016    

Striatal systems and mechanisms regulating L-dopa-induced dyskinesias in Parkinsons disease Investments < €500k United States of America 2016    

Loss of a cohort of axonal mRNAs as a result of reduced SMN levels. Investments < €500k United States of America 2016    

Tongue- and Jaw-Specific Contributions to Vowel Acoustic Changes: Towards a Mechanistic Model of Intelligibility Loss and Recovery in Dysarthria Investments < €500k United States of America 2016    

SYNJ1 Mediates a Novel Signaling Pathway in Parkinsons Disease Investments < €500k United States of America 2016    

Does TDP-43 dysfunction in astrocytes trigger motor neuron degeneration? Investments < €500k United States of America 2016    

Investigating the response of FUS/TLS to excitotoxic insult Investments < €500k United States of America 2016